Williams led development to achieve FDA clearance.
2 reports, 2 independent
Updated Sep 20
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Williams led development to achieve FDA clearance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BriaCell sought IND clearance from the FDA.1 source
Williams led development resulting in FDA clearance.1 source
Keep exploring
The entities involved
Related events
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Experimental therapies require approval from the FDA.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
Coverage
Newest first; wire copies grouped- digitaljournal.com
- GlobeNewswireDr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Compa